SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is facing intense market speculation ahead of its earnings report, with the community deeply divided over whether the company's aggressive investments in robotics, AI, and robotaxi expansion justify its current valuation. Investors are intensely focused on execution metrics, capital intensity, and whether Elon Musk can provide a convincing growth narrative to counter recent delivery concerns and competitive pressures.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is currently seeing heightened volatility and intense debate following reports of integration with new AI agent models, with investors divided between fears of SaaS disruption and long-term bullishness on AI-driven workflow orchestration. Community discussion is heavily focused on the company's upcoming earnings report, as traders look for clarity on subscription growth and AI monetization to determine if the recent pullback represents a structural break or a deep-value entry point.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group ($CAR) is experiencing extreme volatility and a sharp pullback, with the community actively debating whether the stock is undergoing a classic pump-and-dump correction or if retail traders are being trapped in a major liquidity unwind. Investors are fixated on the potential for a continued decline toward lower support levels as the initial parabolic momentum fades and short-sellers move to secure their gains.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is currently generating significant market interest as investors brace for the upcoming earnings report, with options activity suggesting anticipation of a major volatility event. Community discussions are heavily centered on potential defense sector partnerships following recent high-level advisory board appointments, alongside ongoing concerns regarding production scalability and whether upcoming announcements will finally provide the concrete roadmap investors have been waiting for.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Direxion Daily Semiconductor Bear 3X Shares is currently trending as frustrated investors react to a relentless semiconductor sector melt-up and a record-breaking streak of consecutive green days for the underlying index. While the community expresses significant pain and confusion over the lack of pullbacks, many are actively debating the timing of an anticipated volatility spike or market correction as they continue to attempt aggressive dollar-cost averaging.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM shares have experienced a sharp sell-off following market concerns that Anthropic's new AI coding tool could disrupt the company's legacy COBOL modernization business. Despite this, bulls and analysts are pushing back, arguing the market is overreacting by ignoring the company's defensive moats, deep enterprise integration, and prior moves to embed third-party AI into its own governed ecosystem.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is experiencing a massive rally driven by strong investor conviction in its GaN and SiC power chip technology as a key component for next-generation AI data center infrastructure. The community is heavily split between bulls celebrating the breakout and high-beta exposure to Nvidia-related growth, and bears warning of a potential pump-and-dump bubble due to the stock's high valuation and upcoming earnings report.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending as investors react to reports suggesting the Trump administration may soon move to reclassify marijuana, fueling speculation about potential federal reform. The community remains divided, with some bulls anticipating a major breakout on regulatory progress while others express frustration over historical dilution and the company's lack of direct U.S. cannabis revenue.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is rallying sharply as investors celebrate the immediate removal of CEO Peter Greenleaf and a total management overhaul led by new CEO and largest shareholder Kevin Tang. The community is buzzing with optimism that this leadership change, coupled with Tangs decision to decline a salary, signals an aggressive pivot toward maximizing shareholder value and accelerating a potential buyout.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is experiencing a parabolic rally driven by strong AI infrastructure demand and positive analyst sentiment, with momentum traders closely watching for a breach of the psychological $300 level. While many in the community celebrate the stock's massive monthly gains, significant debate persists regarding its high valuation and the sustainability of this run heading into the upcoming earnings report.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Q1 Earnings Forecast for SPRY Issued By Northland Securities

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY - Free Report) - Analysts at Northland Securities issued their Q1 2026 EPS estimates for ARS Pharmaceuticals in a research note issued to investors on Thursday...

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Given Consensus Recommendation of "Hold" by Analysts

Shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY - Get Free Report) have earned a consensus recommendation of "Hold" from the five analysts that are presently covering the stock, Marketbeat Ratings...

ARS Pharmaceuticals (NASDAQ:SPRY) Coverage Initiated by Analysts at Northland Securities

Northland Securities initiated coverage on shares of ARS Pharmaceuticals in a report on Thursday. They issued an "outperform" rating and a $25.00 price target on the stock...

Aberdeen Group plc Purchases 459,027 Shares of ARS Pharmaceuticals, Inc. $SPRY

Aberdeen Group plc raised its position in ARS Pharmaceuticals, Inc. (NASDAQ:SPRY - Free Report) by 14.8% during the fourth quarter, according to its most recent disclosure with the Securities and...

ARS Pharmaceuticals (NASDAQ:SPRY) Shares Up 8% - Should You Buy?

ARS Pharmaceuticals (NASDAQ:SPRY) Shares Up 8% - Should You Buy...

ARS Pharmaceuticals (NASDAQ:SPRY)  Shares Down 5.7%   - Time to Sell?

ARS Pharmaceuticals (NASDAQ:SPRY) Shares Down 5.7% - Here's What Happened...

Bamco Inc. NY Buys 1,228,532 Shares of ARS Pharmaceuticals, Inc. $SPRY

Bamco Inc. NY grew its stake in shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY - Free Report) by 3,071.3% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional...

ARS Pharmaceuticals Q4 Earnings Call Highlights

ARS Pharmaceuticals (NASDAQ:SPRY) executives used the company's fourth-quarter and full-year 2025 earnings call to outline early commercial progress for neffy, its needle-free epinephrine option for...

ARS Pharmaceuticals: Q4 Earnings Insights

ARS Pharmaceuticals, Inc. (SPRY) Reports Q4 Loss, Beats Revenue Estimates

ARS Pharmaceuticals, Inc. (SPRY) delivered earnings and revenue surprises of -0.96% and +9.10%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.

SPRY
ARS Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SPRY News

SPRYARS Pharmaceuticals Inc